Atlas Trials

A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease

Clinical trial NCT02203474 · WITHDRAWN

Trial details

NCT number
NCT02203474
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary DiseaseCOPD
Start date
2014-08-01
Primary completion
2014-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.